trending Market Intelligence /marketintelligence/en/news-insights/trending/IXuVHKTIkZpswVAhLCQ9uw2 content esgSubNav
In This List

Avrobio CFO, chief medical officer to step down; replacement CFO named

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Avrobio CFO, chief medical officer to step down; replacement CFO named

Avrobio Inc. said Katina Dorton and Nerissa Kreher are stepping down as CFO and chief medical officer of the company, respectively.

Erik Ostrowski will replace Dorton as CFO of the company, effective January 2019. Ostrowski was previously CFO of Summit Therapeutics PLC.

Meanwhile, Kreher will continue as a clinical adviser to Avrobio in a transitional role during the first quarter of 2019.

Cambridge, Mass.-based Avrobio develops gene therapies for treating rare diseases.